Cite
HARVARD Citation
Vetter, M. et al. (2022). SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients. Endocrine oncology. 2 (1), pp. 9-18. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vetter, M. et al. (2022). SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients. Endocrine oncology. 2 (1), pp. 9-18. [Online].